Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Mastersizer 3000 Shows Multi-Parameter Capabilities For Catalyst Optimization

Published: Tuesday, December 04, 2012
Last Updated: Tuesday, December 04, 2012
Bookmark and Share
New application note discusses particle sizing, specific surface area and predicting attrition rate in fluidized beds.

A new application note on the Malvern Instruments’ website discusses the criticality of particle size in the development and production of heterogeneous catalyst materials, and presents data to demonstrate the utility of the Mastersizer 3000 particle size analyzer in achieving optimum reactivity.

Not only does the Mastersizer 3000 accurately determine particle size distribution for a wide range of catalyst materials, it also uses the laser diffraction measurement to  calculate specific surface area. And uniquely it offers the ability to predict attrition rate in a fluidized bed from dry powder measurements at different pressures. Download ‘Particle size analysis of catalysts’ at http://www.malvern.com/catalyst

Heterogeneous describes a catalyst that is present in one phase (a solid) with the reactants in another (liquid or gas). For this type of catalyst, the reaction rate depends on the specific surface area of the solid material as this defines the available contact area between catalyst and reactants. Decreasing the particle size of a catalyst in order to increase specific surface area is often a beneficial strategy for improving its reactivity. However, a smaller particle size can be problematic. In some reactions a catalyst with particles that are too fine can cause a number of problems, ranging from health and safety issues due to dust formation through to loss of reactivity through uncontrolled agglomeration. Balancing the efficacy of the catalyst with reducing any risks of having a small particle size means that there is usually an optimum particle size range for a given catalyst.

The Mastersizer 3000 laser diffraction particle size analyzer delivers rapid, accurate particle size distributions for both wet and dry dispersions with the minimum of effort, bringing operator-independent measurements that every user can rely on. It measures over a wide dynamic range from 0.01 - 3500 µm and packs this exceptional performance into the smallest of footprints. Of particular value for the study of catalyst attrition is the power and precision of the integral Aero dry dispersion engine which enables very close control of the dispersion conditions applied. This enables researchers to gain real insight into the propensity of different catalysts to break down during processing.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Malvern takes ACHEMA Visitors from R&D Through to Product QC
Visitors to the Malvern Instruments stand at ACHEMA 2012 will see how the company’s range of complementary materials characterization technologies and instrumentation support the needs of manufacturing industry.
Wednesday, March 28, 2012
Malvern Scientists will lead Protein Characterization Workshop at PEGS Summit
Drs Kevin Mattison, Ulf Nobbmann and Jason Sanchez will lead a workshop at the 7th Annual PEGS.
Tuesday, September 13, 2011
Scientific News
Antibody-Based Drug for Multiple Sclerosis
New antibody-based drug paves the way for new strategies for controlling and treating multiple sclerosis.
Structure of Cold Virus Solved
Researchers have identified the structure of an elusive cold virus linked to child asthma and respiratory infections, providing the foundation for treating the virus.
'Poison Pill' Fed to Deadly Virus
Researchers have created a genetic modification within a virus (with funny name), rendering it unable to replicate, mutate or cause illness.
World First Alzheimer's Vaccine Breakthrough
Researchers have made a breakthrough discovery towards an effective vaccine for Alzheimer's by targeting associated proteins.
Immunotherapy Drug Combo Targets Cancer
Mayo Clinic researchers identify potential immunotherapy drug combination that shows therapeutic effects against advanced and metastatic cancers.
Study Shows Sandoz Biosimilar Equivalent to Originator Drug
New data shows Sandoz biosimilar candidate has equivalent efficacy to originator etanercept following comparison in psoriasis.
Biomunex Confirms Optimal Properties and Activity of BiXAb® Antibodies
Biomunex‘s Plug-and-Play bispecific antibodies demonstrated excellent in vitro properties and in vivo activity positively differentiating their BiXAb platform from competing formats.
Immunotherapy Reduces Rheumatoid-Linked Cardiovascular Risk
Study shows combination of two extra-low dose anticytokines reduces disease activity and cardiovascular events.
Viable HIV Vaccine Confirmed by Study
HIV Study in macaques confirms clinically viable vaccine opening the way for future treatment in humans.
Sanofi Working on Zika Vaccine with U.S. Army
Sanofi is working in conjunction with the U.S. Army to develop possible Zika vaccine at faster rate following research agreement.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!